Vanguard Group Inc Uni Qure N.V. Transaction History

Vanguard Group Inc

$5.97 Trillion
Q2 2025

A detailed history of Vanguard Group Inc transactions in Uni Qure N.V. stock. As of the latest transaction made, Vanguard Group Inc holds 972,691 shares of QURE stock, worth $58.4 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

972,691

Previous 945,466 2.88%

Holding current value

$58.4 Million

Previous $10 Million 35.31%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 11, 2025	BUY	$8.34 - $17.27 $227,056 - $470,175	27,225 Added 2.88%	972,691 $13.6 Million
Q1 2025 May 09, 2025	SELL	$10.6 - $18.08 $1.71 Million - $2.91 Million	-161,135 Reduced 14.56%	945,466 $10 Million
Q4 2024 Feb 11, 2025	SELL	$4.54 - $17.73 $582,686 - $2.28 Million	-128,345 Reduced 10.39%	1,106,601 $19.5 Million
Q3 2024 Nov 13, 2024	BUY	$3.78 - $10.12 $277,520 - $742,990	73,418 Added 6.32%	1,234,946 $6.09 Million
Q2 2024 Aug 13, 2024	BUY	$4.39 - $5.43 $390,674 - $483,226	88,992 Added 8.3%	1,161,528 $5.2 Million
Q1 2024 May 10, 2024	BUY	$4.82 - $6.93 $528,946 - $760,498	109,740 Added 11.4%	1,072,536 $5.58 Million
Q4 2023 Feb 14, 2024	BUY	$5.63 - $8.27 $52,696 - $77,407	9,360 Added 0.98%	962,796 $6.52 Million
Q3 2023 Nov 14, 2023	SELL	$6.71 - $11.83 $2.96 Million - $5.23 Million	-441,830 Reduced 31.67%	953,436 $6.4 Million
Q2 2023 Aug 14, 2023	SELL	$11.12 - $22.2 $160,128 - $319,680	-14,400 Reduced 1.02%	1,395,266 $16 Million
Q1 2023 May 15, 2023	SELL	$18.7 - $23.07 $33,566 - $41,410	-1,795 Reduced 0.13%	1,409,666 $28.4 Million
Q4 2022 Feb 10, 2023	SELL	$18.12 - $27.32 $408,479 - $615,874	-22,543 Reduced 1.57%	1,411,461 $32 Million
Q3 2022 Nov 14, 2022	BUY	$16.98 - $25.54 $2.4 Million - $3.61 Million	141,382 Added 10.94%	1,434,004 $26.9 Million
Q2 2022 Aug 12, 2022	BUY	$13.15 - $20.45 $1.09 Million - $1.69 Million	82,782 Added 6.84%	1,292,622 $24.1 Million
Q1 2022 May 13, 2022	BUY	$14.54 - $21.5 $436,970 - $646,139	30,053 Added 2.55%	1,209,840 $21.9 Million
Q4 2021 Feb 14, 2022	SELL	$20.24 - $36.01 $181,694 - $323,261	-8,977 Reduced 0.76%	1,179,787 $24.5 Million
Q3 2021 Nov 12, 2021	BUY	$26.01 - $38.22 $12 Million - $17.6 Million	461,190 Added 63.39%	1,188,764 $38.1 Million
Q2 2021 Aug 13, 2021	BUY	$29.97 - $37.17 $21.8 Million - $27 Million	727,574 New	727,574 $22.4 Million

Others Institutions Holding QURE

# of Institutions

187

Shares Held

51.8M

Call Options Held

4.43M

Put Options Held

1.27M

View Full List

About uniQure N.V.

Ticker QURE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,729,100
Market Cap $2.8B
Description
uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...

More about QURE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Uni Qure N.V. Transaction History